GGrantIndex
← Leaderboards

Sascha Dublin

Kaiser Foundation Research Institute

$10,789,699
Attributed
$16,714,414
Total exposure
7
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $3.3M · FY200725
$5M$3.8M$2.5M$1.3M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$16,714,414 · 7

By mechanism

R01$15,694,815 · 5
K23$863,999 · 1
R03$155,600 · 1

Top collaborators

Most similar at Kaiser Foundation Research Institute

Same institution · by research overlap

Others in their field

Top investigators on “Alzheimer&Apos

Research focus

Alzheimer&AposWashingtonIntegrated Delivery Of Health CareBaseFutureImpaired CognitionDementiaCommunitiesFollow-UpAffectResearch PersonnelProviderClinical TrialsElderlyPersonsCaliforniaPopulation HeterogeneityDesignHigh RiskObservational StudyRaceCognitiveEducationPerformance

Grant awards (25)

Low-cost detection of dementia using electronic health records data: validation and testing of the eRADAR algorithm in a pragmatic, patient-centered trial.$872,123
R01 · FY2025 · AG · contact PI
Low-cost detection of dementia using electronic health records data: validation and testing of the eRADAR algorithm in a pragmatic, patient-centered trial.$866,304
R01 · FY2024 · AG · contact PI
Identifying and supporting patients with undiagnosed dementia using the EHR Risk of Alzheimer's and Dementia Assessment Rule (eRADAR): a pilot clinical trial$744,989
R01 · FY2023 · AG · contact PI
Low-cost detection of dementia using electronic health records data: validation and testing of the eRADAR algorithm in a pragmatic, patient-centered trial.$826,571
R01 · FY2022 · AG · contact PI
Identifying and supporting patients with undiagnosed dementia using the EHR Risk of Alzheimer's and Dementia Assessment Rule (eRADAR): a pilot clinical trial$765,211
R01 · FY2022 · AG · contact PI
Multidomain Alzheimers Risk Reduction Study (MARRS) Pilot$1,647,910
R01 · FY2021 · AG
Low-cost detection of dementia using electronic health records data: validation and testing of the eRADAR algorithm in a pragmatic, patient-centered trial.$903,251
R01 · FY2021 · AG · contact PI
Identifying and supporting patients with undiagnosed dementia using the EHR Risk of Alzheimer's and Dementia Assessment Rule (eRADAR): a pilot clinical trial$779,617
R01 · FY2021 · AG · contact PI
Identifying and supporting patients with undiagnosed dementia using the EHR Risk of Alzheimer's and Dementia Assessment Rule (eRADAR): a pilot clinical trial$808,490
R01 · FY2020 · AG · contact PI
Low-cost detection of dementia using electronic health records data: validation and testing of the eRADAR algorithm in a pragmatic, patient-centered trial.$650,000
R01 · FY2020 · AG · contact PI
Moderate Hypertension in Pregnancy: Safety and Effectiveness of Treatment$899,269
R01 · FY2018 · HD · contact PI
Moderate Hypertension in Pregnancy: Safety and Effectiveness of Treatment$919,072
R01 · FY2017 · HD · contact PI
Moderate Hypertension in Pregnancy: Safety and Effectiveness of Treatment$1,014,406
R01 · FY2016 · HD · contact PI
Elective Induction of Labor and Pregnancy Outcomes$654,513
R01 · FY2016 · HD · contact PI
Moderate Hypertension in Pregnancy: Safety and Effectiveness of Treatment$1,012,638
R01 · FY2015 · HD · contact PI
Elective Induction of Labor and Pregnancy Outcomes$769,163
R01 · FY2015 · HD · contact PI
Elective Induction of Labor and Pregnancy Outcomes$786,907
R01 · FY2014 · HD · contact PI
Elective Induction of Labor and Pregnancy Outcomes$774,381
R01 · FY2013 · HD · contact PI
Opioids and the Aging Brain: Dementia, Cognitive Decline and Neuropathology$75,600
R03 · FY2013 · AG · contact PI
Opioids and the Aging Brain: Dementia, Cognitive Decline and Neuropathology$80,000
R03 · FY2012 · AG · contact PI
Pharmacepidemiology in the elderly: medications pneumonia risk and confounding$151,692
K23 · FY2011 · AG · contact PI
Pharmacepidemiology in the elderly: medications pneumonia risk and confounding$166,447
K23 · FY2010 · AG · contact PI
Pharmacepidemiology in the elderly: medications pneumonia risk and confounding$197,891
K23 · FY2009 · AG · contact PI
Pharmacepidemiology in the elderly: medications pneumonia risk and confounding$206,271
K23 · FY2008 · AG · contact PI
Pharmacepidemiology in the elderly: medications pneumonia risk and confounding$141,698
K23 · FY2007 · AG · contact PI